Biomarkers – News and Features
News
Metabolon Selected for Membership in NCI Research Group
Metabolon to collaborate with other members to discover and develop biomarkers for the early diagnosis of cancers.
News
Clarient Inc. and Health Discovery Corporation Jointly Announce Licensing Agreement
Clarient licenses HDC's Support Vector Machine patent portfolio in the field of peripheral rare cell detection.
News
Ciphergen and UTMB Sign Collaboration Agreement in Liver Disease
The collaboration will encompass the discovery, validation, and characterization of biomarkers for liver disease.
News
Iconix Announces Collaboration Agreement with Lilly
Lilly will access Iconix's DrugMatrix® chemogenomics system and Drug Signatures® library.
News
Publication Shows Cancer Biomarker Identification in Formalin-Fixed Tissue
The article describes LC MS/MS mass spectrometry analysis of FFPE prostate cancer tissue.
News
Metabolon Appoints Chief Scientific Officer
Dr. Michael Milburn has been appointed as Chief Scientific Officer.
News
FDA and Industry Collaborate to Predict Liver Toxicity in Human Drug Trials
The liver toxicology biomarker study aims to discover signs of human liver toxicity.
News
ALSA Renews Funding for Biomarker Project
Biomarkers for ALS will lead to new insights into the mechanisms of disease.
News
Signature Diagnostics Selects Genedata's Computational Solution
The diagnostics company will use Genedata's software to help them identify unique gene expression profiles found in colorectal cancer patients.
News
Metabolon to Identify Disease Biomarkers for CDC Multiple Sclerosis Study
Metabolon awarded contract from the Centers for Disease Control and Prevention.
Advertisement
